Table 2.
Model and Tertile of ∑As | Incident PAD Status | |||
---|---|---|---|---|
ABI <0.9 | ABI >1.4 | |||
HR | 95% CI | HR | 95% CI | |
Model 1b | ||||
1 (lowest) | 1.00 | Referent | 1.00 | Referent |
2 | 1.06 | 0.65, 1.55 | 1.41 | 0.90, 2.26 |
3 (highest) | 0.63 | 0.39, 0.92 | 1.63 | 0.99, 2.67 |
Model 2c | ||||
1 (lowest) | 1.00 | Referent | 1.00 | Referent |
2 | 1.06 | 0.62, 1.56 | 1.40 | 0.80, 2.50 |
3 (highest) | 0.57 | 0.32, 0.89 | 1.71 | 0.96, 3.29 |
Model 3d | ||||
1 (lowest) | 1.00 | Referent | 1.00 | Referent |
2 | 1.10 | 0.66, 1.72 | 1.80 | 0.93, 3.35 |
3 (highest) | 0.59 | 0.33, 1.04 | 2.40 | 1.11, 4.95 |
Abbreviations: ABI, ankle brachial index; CI, confidence interval; HR, hazard ratio; PAD, peripheral arterial disease; ∑As, sum of inorganic and methylated urinary arsenic species.
a Tertiles 1, 2, and 3 included participants with ∑As values of ≤7.07 μg/g, 7.07–13.3 μg/g, and >13.3 μg/g, respectively.
b Model 1 adjusted for sex and age.
c Model 2 adjusted for sex and age and further adjusted for education, smoking, body mass index, low-density lipoprotein cholesterol, diabetes, hypertension, and estimated glomerular filtration rate.
d Model 3 adjusted for all of the variables in model 2 and further adjusted for study center.